We are live on
!
Find out more
MCP
Martin Capital Partners Portfolio holdings
AUM
$272M
1-Year Est. Return
19.09%
This Fund
S&P 500
This Quarter
Est. Return
-6.97%
1 Year Est. Return
+19.09%
3 Year Est. Return
+35.19%
5 Year Est. Return
+47.96%
10 Year Est. Return
–
AUM
$211M
AUM Growth
-$8.27M
(-3.8%)
Cap. Flow
+$9.22M
Cap. Flow
% of AUM
4.37%
Top 10 Holdings %
Top 10 Hldgs %
30.36%
Holding
72
New
2
Increased
47
Reduced
21
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Phillips 66
PSX
|
+$2.93M |
| 2 |
MPT
Medical Properties Trust
MPT
|
+$2.81M |
| 3 |
VF Corp
VFC
|
+$1.95M |
| 4 |
Unilever
UL
|
+$575K |
| 5 |
Intel
INTC
|
+$361K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Scotiabank
BNS
|
+$1.56M |
| 2 |
Chevron
CVX
|
+$1.49M |
| 3 |
ISBC
Investors Bancorp, Inc.
ISBC
|
+$367K |
| 4 |
Jack Henry & Associates
JKHY
|
+$136K |
| 5 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$35.9K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.42% |
| 2 | Industrials | 15.49% |
| 3 | Consumer Staples | 14.06% |
| 4 | Financials | 11.3% |
| 5 | Technology | 10.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Pfizer
PFE
$140B
| $7.38M | 3.5% |
140,699
+6,788
| +5% | +$346K |
|
|
2
Unilever
UL
$131B
| $7.08M | 3.36% |
137,338
+11,285
| +9% | +$575K |
|
3
Johnson & Johnson
JNJ
$635B
| $6.95M | 3.3% |
39,133
+915
| +2% | +$163K |
|
4
Verizon
VZ
$194B
| $6.47M | 3.07% |
127,567
+4,382
| +4% | +$222K |
|
5
Amgen
AMGN
$203B
| $6.4M | 3.04% |
26,319
+1,271
| +5% | +$311K |
|
6
General Dynamics
GD
$105B
| $6.17M | 2.93% |
27,883
+569
| +2% | +$131K |
|
7
ExxonMobil
XOM
$651B
| $5.99M | 2.84% |
69,945
-265
| -0.4% | -$23.9K |
|
8
Merck
MRK
$324B
| $5.93M | 2.81% |
65,024
+1,595
| +3% | +$141K |
|
9
Coca-Cola
KO
$354B
| $5.89M | 2.8% |
93,690
-95
| -0.1% | -$6.02K |
|
10
JPMorgan Chase
JPM
$939B
| $5.72M | 2.71% |
50,804
+2,793
| +6% | +$346K |
|
11
United Parcel Service
UPS
$97.6B
| $5.42M | 2.57% |
29,712
+970
| +3% | +$177K |
|
12
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
| $5.41M | 2.57% |
181,895
-907
| -0.5% | -$27.1K |
|
13
Texas Instruments
TXN
$255B
| $5.4M | 2.56% |
35,116
+411
| +1% | +$69.1K |
|
14
Public Service Enterprise Group
PEG
$39.8B
| $5.34M | 2.54% |
84,448
+1,353
| +2% | +$92K |
|
|
15
Chevron
CVX
$388B
| $5.31M | 2.52% |
36,686
-9,038
| -20% | -$1.49M |
|
16
MSC Industrial Direct
MSM
$7.02B
| $5.23M | 2.48% |
69,577
+1,768
| +3% | +$145K |
|
17
US Bancorp
USB
$99.6B
| $5.16M | 2.45% |
112,075
+3,596
| +3% | +$180K |
|
18
Lockheed Martin
LMT
$134B
| $5.16M | 2.45% |
11,989
+65
| +0.5% | +$28.5K |
|
|
19
Intel
INTC
$466B
| $5.1M | 2.42% |
136,292
+8,354
| +7% | +$361K |
|
20
Procter & Gamble
PG
$343B
| $5.03M | 2.39% |
34,984
+1,021
| +3% | +$153K |
|
21
Cisco
CSCO
$450B
| $4.99M | 2.37% |
116,942
+5,637
| +5% | +$270K |
|
|
22
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
| $4.57M | 2.17% |
90,451
-706
| -0.8% | -$35.9K |
|
23
UnitedHealth
UNH
$382B
| $4.51M | 2.14% |
8,780
+27
| +0.3% | +$13.6K |
|
24
Microsoft
MSFT
$2.84T
| $4.44M | 2.1% |
17,274
-96
| -0.6% | -$26.1K |
|
25
Medtronic
MDT
$107B
| $4.41M | 2.09% |
49,154
+1,673
| +4% | +$170K |
|
Similar funds
SC
SC
BLAM
TP
AGP
SFPG
S
SS
Martin Capital Partners's Q2 2022 Portfolio in Review
As of Q2 2022, Martin Capital Partners held 72 positions worth $211M, down 3.8% from $219M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Martin Capital Partners deployed $9.22M of net new capital in Q2 2022, opening 2 new positions and adding to 47 existing holdings. Its largest new stake was Phillips 66: 31,719 shares worth $2.6M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Industrials and Consumer Staples.
On the sell side, the largest reduction was Scotiabank, an estimated $1.56M trimmed.
- Martin Capital Partners's largest Q2 2022 buy was Phillips 66: 31,719 shares worth $2.6M.
- Martin Capital Partners added most to Medical Properties Trust in Q2 2022, an estimated $2.81M increase.
- Martin Capital Partners's biggest Q2 2022 reduction was Scotiabank, cutting an estimated $1.56M.
- Martin Capital Partners fully exited Investors Bancorp, Inc. in Q2 2022, selling an estimated $367K.
- Martin Capital Partners's ten largest holdings make up 30% of its $211M portfolio in Q2 2022.
- Martin Capital Partners opened 2 new positions and closed 1 in Q2 2022.
- Martin Capital Partners's portfolio value fell 3.8% quarter-over-quarter to $211M.
Based on Martin Capital Partners's 13F filing for Q2 2022, filed 8 Jul 2022.